Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas

PHASE3CompletedINTERVENTIONAL
Enrollment

528

Participants

Timeline

Start Date

November 9, 2018

Primary Completion Date

August 16, 2021

Study Completion Date

January 2, 2022

Conditions
Pancreatic Cancer Metastatic
Interventions
DRUG

CPI 613, mFolfirinox

CPI-613: 500mg/m2, IV infusion at a rate of 4mL/min via a central venous port. mFolfirinox: given immediately after CPI-613 administration

DRUG

Folfirinox

Folfirinox

Trial Locations (74)

1070

Hôpital Erasme, Brussels

2841

Korea University Anam Hospital, Seoul

3000

UZ Leuven, Leuven

3722

Severance Hospital - Yonsei Cancer Center, Seoul

6351

Samsung Medical Center, Seoul

6591

National Cancer Center, Seoul

10016

New York University Langone Medical Center, New York

11794

Stony Brook University Hospital, Stony Brook

13620

Seoul National University Bundang Hospital, Seongnam-si

14263

Roswell Park Cancer Institute, Buffalo

15232

University of Pittsburgh-Hillman cancer ceter, Pittsburgh

16499

Ajou University Hospital, Suwon

20007

Georgetown University Medical Center, Washington D.C.

21556

Gachon University Gil Hospital, Incheon

22332

Inha University Hospital, Incheon

22908

University of Virginia Cancer Center - Emily Couric Clinical Cancer Center, Charlottesville

23298

VCU Massey Cancer Center, Richmond

24014

Blue Ridge Cancer Care, Roanoke

27157

Wake Forest Baptist Health, Winston-Salem

27599

UNC Lineberger Comprehensive Cancer Center, Chapel Hill

28204

Levine cancer Institute, Charlotte

29609

CHRU Brest - Hôpital Morvan, Brest

31096

Rambam Medical Center, Haifa

32224

Mayo Clinic Hospital, Jacksonville

33140

Mount Sinai Medical Center, Miami Beach

33600

CHU Hopitaux de Bordeaux - Hôpital Saint-André, Pessac

34000

L'ICM, Institut régional du Cancer de Montpellier, Montpellier

35042

Centre Eugène Marquis, Rennes

37232

Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center-Henry-Joyce Cancer Clinic, Nashville

38101

Hillel Yaffe Medical Center, Hadera

41944

Kyungpook National University Chilgok Hospital, Daegu

42150

Sanz Medical Center - Laniado Hospital, Netanya

44093

CHU de Nantes - Hôpital Nord Laennec, Nantes

44106

Cleveland Clinic - Taussig Cancer Center, Cleveland

University Hospitals - Seidman Cancer Center, Cleveland

44791

Universitätsklinikum Knappschaftskrankenhaus Bochum GmbH, Bochum

45267

University of Cincinnati Cancer Institute, Cincinnati

48109

University of Micihgan, Ann Arbor

48201

Karmanos cancer Center, Detroit

49201

Seoul National University Hospital, Busan

52621

The Chaim Sheba Medical Center - Sheba Cancer Research Center (SCRC), Ramat Gan

54500

Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy

55905

Mayo Clinic Cancer Center (MCCC), Rochester

60426

University of Chicago, Harvey

60611

Northwestern Memorial Hospital - Arkes Family Pavilion, Chicago

62431

Tel Aviv Sourasky Medical Center, Tel Aviv

63110

Washington University, St Louis

66205

The University of Kansas Cancer Center - Clinical Research Center - Fairway Office Park, Fairway

70300

Assaf-Harofeh Medical Center, Ẕerifin

72076

Universitaetsklinikum Tuebingen, Tübingen

74078

SLK-Kliniken Heilbronn GmbH, Heilbronn

77030

The University of Texas MD Anderson Cancer Center, Houston

84112

Huntsman cancer Institute, Salt Lake City

85234

Banner MD Anderson Cancer Center, Gilbert

85724

The University of Arizona Cancer Center, Tucson

85925

Centre Hospitalier Départemental Vendée - Hôpital de la Roche-sur-Yon, La Roche-sur-Yon

86000

CHU de Poitiers, Poitiers

87102

University of New Mexico Cancer Center, Albuquerque

89148

Comprehensive Cancer centers of Nevada, Las Vegas

90033

USC Norris Comprehensive Cancer Center, Los Angeles

90404

UCLA Medical Center, Los Angeles

91010

City of Hope, Duarte

91031

Shaare Zedek Medical Center, Jerusalem

92110

Hôpital Beaujon, Clichy

94115

Pacific Hematology Oncology Associates, San Francisco

94805

Gustave Roussy Cancer Campus Grand Paris (Institut de Cancerologie Gustave-Roussy), Villejuif

97239

Oregon Health and Science University, Portland

98109

Seattle Cancer Care Alliance, Seattle

06511

Smilow Cancer Hospital at Yale-New Haven, New Haven

01655

University of Massachusetts Memorial Medical Center, Worcester

07631

Englewood Hospital and Medical Center, Englewood

07962

Atlantic Health System, Morristown

Unknown

The Catholic University of Korea - Seoul St. Mary's Hospital (Kangnam St. Mary's Hospital), Seocho

03080

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Cornerstone Pharmaceuticals

INDUSTRY

NCT03504423 - Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas | Biotech Hunter | Biotech Hunter